Calendar

Week of Apr 27, 2026

Apr 27, 2026phase 1 initiation107d agoNational Institute of Neurological Disorders and Stroke — pembrolizumab (Phase I Trial Initiation)pembrolizumab

Therapy area: Infectious Disease. Indication: Coronavirus Disease 2019 (COVID-19), Post-Acute Sequelae of COVID 2019 (PASC or Long COVID)

full page →pembrolizumab →source: globaldata

Apr 27, 2026constraining patent expiry europe107d agoBill & Melinda Gates Medical Research Institute — SB-692342 (Constraining Patent Expiry (Europe))SB-692342

Therapy area: Infectious Disease. Indication: Pulmonary Tuberculosis

full page →SB-692342 →source: globaldata

Apr 27, 2026patent expiry107d agoBill & Melinda Gates Medical Research Institute — SB-692342 (Constraining Patent Expiry (Japan))SB-692342

Therapy area: Infectious Disease. Indication: Pulmonary Tuberculosis

full page →SB-692342 →source: globaldata

Apr 27, 2026phase 2 completion107d agoEuropean and Developing Countries Clinical Trials Partnership — (diphtheria + tetanus + pertussis (whole cell) + hepatitis B + haemophilus influenzae [serotype B]) vaccine (Phase II Trial Completion)(diphtheria + tetanus + pertussis (whole cell) + hepatitis B + haemophilus influenzae [serotype B]) vaccine

Therapy area: Infectious Disease. Indication: Salmonella Infections

full page →(diphtheria + tetanus + pertussis (whole cell) + hepatitis B + haemophilus influenzae [serotype B]) vaccine →source: globaldata

Apr 27, 2026phase 2 initiation107d agoNational Institute of Neurological Disorders and Stroke — brincidofovir (Phase II Trial Initiation)brincidofovir

Therapy area: Infectious Disease. Indication: Progressive Multifocal Leukoencephalopathy

full page →brincidofovir →source: globaldata

Apr 27, 2026phase 3 completion107d agoSanofi — meningococcal [serotypes A, C, W-135, Y] vaccine (MenQuadfi) (Phase III Trial Completion)meningococcal [serotypes A, C, W-135, Y] vaccine (MenQuadfi)

Therapy area: Infectious Disease. Indication: Neisseria meningitidis Infections

full page →meningococcal [serotypes A, C, W-135, Y] vaccine (MenQuadfi) →source: globaldata

Apr 27, 2026phase iv trial initiation107d agoAll India Institute of Medical Sciences Patna — typhoid Vi polysaccharide vaccine (Phase IV Trial Initiation)typhoid Vi polysaccharide vaccine

Therapy area: Infectious Disease. Indication: Typhoid Fever

full page →typhoid Vi polysaccharide vaccine →source: globaldata

Week of Apr 27, 2026